Sophie Testa

Comparison between different <scp>D</scp>‐<scp>D</scp>imer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the <scp>DULCIS</scp> study

Gualtiero Palareti, Cristina Legnani, Benilde Cosmi et al. · International Journal of Laboratory Hematology · 2015 · 886 citations · Full text

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro et al. · Blood · 2018 · 769 citations · Full text

<scp>d</scp> -Dimer Testing to Determine the Duration of Anticoagulation Therapy

Gualtiero Palareti, Benilde Cosmi, Cristina Legnani et al. · New England Journal of Medicine · 2006 · 618 citations

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Journal of Thrombosis and Haemostasis · 2009 · 605 citations · Full text

Clinical Course, Thrombosis, Lipid Disorder +8

A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Guido Finazzi, Roberto Marchioli, Vincenzo Brancaccio et al. · Journal of Thrombosis and Haemostasis · 2005 · 582 citations · Full text

Thrombosis, Randomized Clinical Trial, Cardiovascular Disease +7